Huanglong Antitussive Granule Relieves Acute Asthma Through Regulating Pulmonary Lipid Homeostasis

Abstract

Background: Asthma is a respiratory disease with chronic airway inflammatory, and individuals with asthma exacerbations is one of the most frequent causes of hospitalization. Huanglong antitussive granule (HL Granule), a Chinese proprietary herbal medicine, has been proved to be effective in the clinical treatment of pulmonary disease. This study is devoted to the pharmacodynamics of HL Granule in acute asthma and the possible mechanism from the perspective of lipidomics.Methods: Mice were divided into four groups, control group, acute asthma model group, HL Granule treatment and montelukast sodium treatment group. Acute asthma was induced by ovalbumin (OVA). Histopathology, pulmonary function and enzyme linked immunosorbent assay (ELISA) were used to validated model and effect of HL Granule. Lipids were detected by ultra-high-performance liquid chromatography coupled to hybrid Quadrupole-Exactive Orbitrap mass spectrometry (UHPLC-Q-Exactive Orbitrap MS) and identified by MS-DAIL and built-in Lipidblast database. Differentially expressed lipids recalled in HL Granule treatment group were extracted for heatmap, enrichment analysis and correlation analysis.Results: HL Granule was effective in decreasing airway hyperresponsiveness (AHR), airway inflammatory and the levels of IL-4 and IL-5. A total of 304 and 167 lipids were identified in positive and negative ion mode, respectively. Among these, 104 and 73 lipids were reserved in HL Granule group (FDR < 0.05), including acylcarnitine (ACar), fatty acid (FA), lysophosphatidylcholine (LPC), phosphatidylcholine (PC), lysophosphatidylethanolamine (LPE), phosphatidylethanolamine (PE), phosphatidylglycerol (PG), phosphatidylinositol (PI), phosphatidylserine (PS), diglyceride (DG), triglyceride (TG), sphingomyelin (SM) and ceramide (Cer). Furthermore, 118 and 273 correlations among 47 and 96 lipids in the positive and negative were observed, with ether-linked phosphatidylethanolamine (PEe) and phosphatidylcholine (PCe) (FDR < 0.001, Spearman correlation coefficient r2 > 0.75).Conclusion: HL Granule might improve pulmonary lipid homeostasis and could be used as an alternative or supplementary therapy in clinical for the treatment of asthma.

Integrative network pharmacology and molecular docking to reveal the mechanism of Jinqiaomai tablet on asthma

“…Traditional Chinese medicine (TCM) preparations contain a number of active ingredients that exhibit synergistic effects on multiple targets at the same time(8). TCM has currently been widely used in China to treat asthma, whether alone or in combination with conventional asthma medications (9). Fagopyrum cymosum, known as golden buckwheat (Jinqiaomai) in China, is a perennial herb that belongs to the Fagopyrum genus within the Polygonaceae family (10).…”

Potential cellular endocrinology mechanisms underlying the effects of Chinese herbal medicine therapy on asthma

“…However, this combination has some potential pharmacological risks like cardiac arrhythmia ( 17 ). Currently, traditional Chinese medicine (TCM), owing to their unique curative effects without the development of significant toxic side effects, has been widely applied in the treatment of asthma in China ( 18 ). Thus, under the guidance of cellular endocrinology, it has gradually attracted the attention of researchers for known effective TCM extracts, single herbs, traditional Chinese patent medicine, and compound prescriptions for the treatment of asthma to be selected and for the underlying molecular mechanisms to be revealed.…”